Is lamivudine with 1-week HBlg as effective as long-term high-dose HBlg in HBV prophylaxis after liver transplantation?

Transplant Proc. 2002 Jun;34(4):1252-4. doi: 10.1016/s0041-1345(02)02637-4.

Authors

S-J Park¹, S W Paik, M S Choi, J H Lee, K C Koh, S J Kim, J W Joh, S K Lee

Affiliation

¹ Division of Gastroenterology, Samsung Medical Center, Sungkyunkwan Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

PMID: 12072331
DOI: 10.1016/s0041-1345(02)02637-4

No abstract available

Publication types

Clinical Trial
Comparative Study
Randomized Controlled Trial

MeSH terms

Adult
Disease-Free Survival
Drug Administration Schedule
Female
Follow-Up Studies
Hepatitis B / drug therapy*
Hepatitis B / surgery*
Humans
Immunization, Passive
Immunoglobulins / therapeutic use*
Lamivudine / therapeutic use*
Liver Transplantation / mortality
Liver Transplantation / physiology*
Male
Prospective Studies
Recurrence
Retrospective Studies
Reverse Transcriptase Inhibitors / therapeutic use*
Survival Rate
Time Factors

Substances

Immunoglobulins
Reverse Transcriptase Inhibitors
Lamivudine
hepatitis B hyperimmune globulin